Structural basis for specificity and potency of xanthine derivatives as activators of the CFTR chloride channelBRITISH JOURNAL OF PHARMACOLOGYIF7.72009-02-0357OAAI
Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07BRITISH JOURNAL OF PHARMACOLOGYIF7.72009-02-0258OAAI
Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channelsJOURNAL OF MEDICINAL CHEMISTRYIF6.82004-01-1761PREAI
Isolation of drugs active against mammalian prions using a yeast-based screening assayNATURE BIOTECHNOLOGYIF41.72003-08-10178OAAI
Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effectsJOURNAL OF MEDICINAL CHEMISTRYIF6.82002-12-18188PREAI
Photodegradation study of a new activator of the cystic fibrosis chloride channel, the 6-hydroxy-10-chlorobenzo[c]quinolizinium chloride (MPB-07)JOURNAL OF PHARMACEUTICAL SCIENCESIF3.82002-02-011PREAI
Activation of G551D CFTR channel with MPB-91:: regulation by ATPase activity and phosphorylationAMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGYIF4.72001-11-0137PREAI
Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cellsAMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGYIF4.72000-12-0131PREAI
Development of substituted benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channelJOURNAL OF BIOLOGICAL CHEMISTRYIF3.91999-09-01102OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向